206 related articles for article (PubMed ID: 14740638)
1. Cancer pharmacogenetics: polymorphisms, pathways and beyond.
Ulrich CM; Robien K; McLeod HL
Nat Rev Cancer; 2003 Dec; 3(12):912-20. PubMed ID: 14740638
[No Abstract] [Full Text] [Related]
2. Pharmacogenomics of cancer chemotherapy-induced toxicity.
Miller CR; McLeod HL
J Support Oncol; 2007 Jan; 5(1):9-14. PubMed ID: 17265780
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy.
Robaey P; Krajinovic M; Marcoux S; Moghrabi A
Dev Disabil Res Rev; 2008; 14(3):211-20. PubMed ID: 18924160
[TBL] [Abstract][Full Text] [Related]
4. Using genetic variation to optimize cancer chemotherapy.
McLeod HL; Papageorgio C; Watters JW
Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of cytotoxic drugs.
Daly AK; Hall AG
Expert Rev Anticancer Ther; 2001 Aug; 1(2):301-8. PubMed ID: 12113035
[TBL] [Abstract][Full Text] [Related]
6. Cancer pharmacogenetics.
Marsh S
Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics in cancer treatment.
Nagasubramanian R; Innocenti F; Ratain MJ
Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
Hasegawa Y
Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics for individualized cancer chemotherapy.
Efferth T; Volm M
Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
[TBL] [Abstract][Full Text] [Related]
10. Drug methylation in cancer therapy: lessons from the TPMT polymorphism.
Krynetski E; Evans WE
Oncogene; 2003 Oct; 22(47):7403-13. PubMed ID: 14576848
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
12. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
Mladosievicova B; Carter A; Kristova V
Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847
[TBL] [Abstract][Full Text] [Related]
13. Infusion of pharmacogenetics into cancer care.
Prows CA
Semin Oncol Nurs; 2011 Feb; 27(1):45-53. PubMed ID: 21255712
[TBL] [Abstract][Full Text] [Related]
14. CYP450 pharmacogenetics for personalizing cancer therapy.
van Schaik RH
Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
[TBL] [Abstract][Full Text] [Related]
15. Challenges in the development and use of pharmacogenomic markers in oncology.
Innocenti F
J Support Oncol; 2007 Jan; 5(1):15-6. PubMed ID: 17265781
[No Abstract] [Full Text] [Related]
16. [Value and applications of pharmacogenetics in oncology and hematology].
Albin N; Massade L; Gouyette A
Bull Cancer; 1997 Jun; 84(6):643-51. PubMed ID: 9295869
[TBL] [Abstract][Full Text] [Related]
17. Genetic profiling can predict chemotherapy side effects and treatment response.
Expert Rev Mol Diagn; 2003 Jul; 3(4):406-7. PubMed ID: 12877380
[No Abstract] [Full Text] [Related]
18. Pharmacogenomics of colorectal cancer prevention and treatment.
Nguyen H; Tran A; Lipkin S; Fruehauf JP
Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
[TBL] [Abstract][Full Text] [Related]
19. Introduction.
;
Invest New Drugs; 2005 Dec; 23(6):511. PubMed ID: 16391895
[No Abstract] [Full Text] [Related]
20. Somatic pharmacogenomics in cancer.
Ikediobi ON
Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]